Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE1193.7021.2 (+1.81 %)

PREV CLOSE ( ) 1172.50

OPEN PRICE ( ) 1171.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12937

TODAY'S LOW / HIGH ( )1169.65 1199.40

52 WK LOW / HIGH ( )994.35 1364.95

NSE1195.1022.9 (+1.95 %)

PREV CLOSE( ) 1172.20

OPEN PRICE ( ) 1175.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1195.10 (1112)

VOLUME 670100

TODAY'S LOW / HIGH( ) 1170.40 1199.50

52 WK LOW / HIGH ( )1010 1356.2

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

50662.90

43799.90

26125.00

33727.40

73435.90

Adjustment

18341.60

14962.40

15864.70

13441.30

-16626.40

Changes In working Capital

-12444.80

-16750.70

-10949.80

15578.00

-10666.50

Cash Flow after changes in Working Capital

56559.70

42011.60

31039.90

62746.70

46143.00

Cash Flow from Operating Activities

39246.20

24345.20

23867.50

50164.80

33290.50

Cash Flow from Investing Activities

-18758.00

-42559.50

-39777.50

-32115.60

5986.90

Cash Flow from Financing Activities

1197.80

8004.20

18144.10

-29692.70

-13649.40

Net Cash Inflow / Outflow

21686.00

-10210.10

2234.10

-11643.50

25628.00

Opening Cash & Cash Equivalents

33854.30

43922.70

41625.10

53299.10

27468.20

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

6.60

64.10

-32.50

224.10

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

91.00

141.70

-0.60

2.00

-21.20

Closing Cash & Cash Equivalent

55637.90

33854.30

43922.70

41625.10

53299.10